Combivent and Chest pain - a phase IV clinical study of FDA data

Summary:

Chest pain is found among people who take Combivent, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Combivent and have Chest pain. It is created by eHealthMe based on reports of 33,495 people who have side effects when taking Combivent from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Apr, 05, 2023

33,495 people reported to have side effects when taking Combivent.
Among them, 1,901 people (5.68%) have Chest pain.

What is Combivent?

Combivent has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 33,727 Combivent users for its effectiveness, alternative drugs and more.

What is Chest pain?

Chest pain is found to be associated with 4,894 drugs and 4,720 conditions by eHealthMe.

Number of Combivent and Chest pain reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Combivent and have Chest pain?

Check whether Chest pain is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .

Related studies

How severe was Chest pain and when was it recovered:

Chest pain in Combivent

Expand to all the drugs that have ingredients of albuterol sulfate; ipratropium bromide:

Chest pain and drugs with ingredients of albuterol sulfate; ipratropium bromide (1,937 reports)

Alternative drugs to, pros and cons of Combivent:

Combivent (33,727 reports)

Common Combivent side effects:

Breathing difficulty: 6,067 reports
Drug ineffective: 3,360 reports
Pneumonia: 2,302 reports
Cough: 2,195 reports
Chest pain: 1,901 reports
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe): 1,763 reports
Asthma: 1,761 reports

Browse all side effects of Combivent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Chest pain treatments and more:

Chest pain (325,666 reports)

COVID vaccines that are related to Chest pain:

Common drugs associated with Chest pain:

All the drugs that are associated with Chest pain:

Chest pain (4,894 drugs)

Common conditions associated with Chest pain:

High blood pressure: 15,249 reports
Asthma: 13,835 reports
Rheumatoid arthritis: 13,819 reports
Multiple sclerosis: 12,065 reports
Primary pulmonary hypertension: 9,982 reports
Pain: 9,333 reports

All the conditions that are associated with Chest pain:

Chest pain (4,720 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate; ipratropium bromide (the active ingredients of Combivent) and Combivent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.